title: Rift Valley Fever among febrile patients at New Halfa hospital, eastern Sudan.
abstract: BACKGROUND
  Since the first isolation of the Rift Valley Fever virus (RVFV) in 1930s, there have been several epizootics outbreaks in the tropic mainly in Africa including Sudan. Recognition of cases and diagnosis of RVF are critical for management and control of the disease.
  
  
  OBJECTIVE
  To investigate the seroprevalence and risk factors for seropositive to RVFV IgG among febrile patients.
  
  
  METHODS
  All febrile patients presented to New Halfa hospital in eastern Sudan during September through November 2007 were investigated to identify the cause of their fever including malaria and RFV.
  
  
  RESULTS
  Out of 290 feverish patients presented to the hospital, malaria was diagnosis in 94 individuals. Fevers of unknown origin were diagnosed in 149 patients. Seropositive to RVFV IgG was detected by enzyme-linked immunosorbent assay in 122 (81.8%) of the sera from these 149 patients with fever of unknown origin. While socio-demographic characteristics (age, Job, education and residency) were not associated with seropositive to RVFV IgG, male (OR = 2.8, 95% CI = 1.0-7.6; P = 0.04) were at three times higher risk for seropositive to RVFV IgG.
  
  
  CONCLUSIONS
  There was a high seropositive to RVFV IgG in this setting, more research is needed perhaps using other methods like PCR and IGM.
authors.affiliation: Faculty of Medicine, University of Khartoum, Khartoum, Sudan.
authors.forename: Ahmed M
authors.initials: AM
authors.lastname: Hassanain
authors.forename: Waleed
authors.initials: W
authors.lastname: Noureldien
authors.forename: Mubarak S
authors.initials: MS
authors.lastname: Karsany
authors.forename: El Najeeb S
authors.initials: el NS
authors.lastname: Saeed
authors.forename: Imadeldin E
authors.initials: IE
authors.lastname: Aradaib
authors.forename: Ishag
authors.initials: I
authors.lastname: Adam
mesh_terms: D000328:Adult; D000914:Antibodies, Viral / Q000097:blood*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006761:Hospitals; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D012295:Rift Valley Fever / Q000453:epidemiology*; D012296:Rift Valley fever virus / Q000276:immunology / Q000302:isolation & purification*; D012307:Risk Factors; D016036:Seroepidemiologic Studies; D012737:Sex Factors; D013397:Sudan / Q000453:epidemiology
chemical_list: D000914:Antibodies, Viral; D007074:Immunoglobulin G
references.citation: Emerg Infect Dis. 2002 Dec;8(12):1415-20
references.pmid: 12498657
references.citation: Am J Trop Med Hyg. 1993 May;48(5):676-81
references.pmid: 8517485
references.citation: Vet Microbiol. 2007 Apr 15;121(3-4):249-56
references.pmid: 17257783
references.citation: Wkly Epidemiol Rec. 2007 Nov 30;82(48):417-8
references.pmid: 18050533
references.citation: Clin Infect Dis. 2003 Oct 15;37(8):1084-92
references.pmid: 14523773
references.citation: J Trop Med Hyg. 1981 Apr;84(2):63-6
references.pmid: 7218404
references.citation: J Med Virol. 1996 Feb;48(2):141-6
references.pmid: 8835346
references.citation: Int J Infect Dis. 2010 Feb;14(2):e179-80
references.pmid: 19570703
references.citation: East Mediterr Health J. 2005 May;11(3):499-504
references.pmid: 16602473
references.citation: Prev Vet Med. 2007 Nov 15;82(1-2):72-82
references.pmid: 17570545
references.citation: Wkly Epidemiol Rec. 1998 Apr 10;73(15):105-9
references.pmid: 9577708
references.citation: J Med Virol. 2008 May;80(5):929
references.pmid: 18360907
references.citation: Clin Infect Dis. 2003 Feb 1;36(3):245-52
references.pmid: 12539063
references.citation: Emerg Infect Dis. 2002 Feb;8(2):138-44
references.pmid: 11897064
references.citation: BMC Infect Dis. 2010 Mar 11;10:65
references.pmid: 20222979
references.citation: Ann Trop Med Parasitol. 2004 Oct;98(7):661-6
references.pmid: 15509420